September 12, 2024
DUPIXENT® (Dupilumab Injection) Approved in Canada for the Treatment of Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)
July 25, 2024
Ontario Ministry of Health Announces a Universal Public Program with Beyfortus® this RSV Season
No current content.